These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevalence of antimicrobial resistance among pneumococcal isolates from children with otitis media in southern Israel. Goldbart A, Yagupsky P, Markus N, Fraser D, Dagan R. Pediatr Infect Dis J; 1997 May; 16(5):521-3. PubMed ID: 9154549 [No Abstract] [Full Text] [Related]
10. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Eldan M, Leibovitz E, Piglansky L, Raiz S, Press J, Yagupsky P, Leiberman A, Dagan R. Pediatr Infect Dis J; 2000 Apr; 19(4):298-303. PubMed ID: 10783018 [Abstract] [Full Text] [Related]
12. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B. Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971 [Abstract] [Full Text] [Related]
13. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Bottenfield GW, Burch DJ, Hedrick JA, Schaten R, Rowinski CA, Davies JT. Pediatr Infect Dis J; 1998 Oct; 17(10):963-8. PubMed ID: 9802654 [No Abstract] [Full Text] [Related]